The accuracy of the SONOBREAST statistical model in comparison to BI-RADS for the prediction of malignancy in solid breast nodules detected at ultrasonography. (January 2016)

• Record Type: Journal Article
• Authors: Paulinelli, Regis R.; Oliveira, Luis-Fernando P.; Freitas-Junior, Ruffo; Soares, Leonardo R.
• Is Part Of: European journal of obstetrics, gynecology, and reproductive biology. Volume 196(2016:Jan.)
• Page Start: 1
• Page End: 5
• Publication Date: 2016-01
• Subjects: Breast cancer -- Ultrasonography -- Diagnosis -- Sensitivity and specificity -- SONOBREAST; Obstetrics -- Periodicals; Gynecology -- Periodicals; Reproductive health -- Periodicals; Gynecology -- Periodicals; Obstetrics -- Periodicals; Reproduction -- Periodicals; Obstétrique -- Périodiques; Gynécologie -- Périodiques; Reproduction -- Périodiques; Verloskunde; Gynaecologie; Voortplanting (biologie); Gynecology; Obstetrics; Reproduction; Electronic journals; Periodicals; Electronic journals; 618.05
• DOI: 10.1016/j.ejogrb.2015.09.031
• Languages: English
• ISSNs: 0301-2115

Abstract

Abstract: Objective: The objective of the present study was to compare the accuracy of SONOBREAST for the prediction of malignancy in solid breast nodules detected at ultrasonography with that of the BI-RADS system and to assess the agreement between these two methods. Study design: This prospective study included 274 women and evaluated 500 breast nodules detected at ultrasonography. The probability of malignancy was calculated based on the SONOBREAST model, available atwww.sonobreast.com.br, and on the BI-RADS system, with results being compared with the anatomopathology report. Results: The lesions were considered suspect in 171 cases (34.20%), according to both SONOBREAST and BI-RADS. Agreement between the methods was perfect, as shown by a Kappa coefficient of 1 ( p < 0.001). SONOBREAST and BI-RADS proved identical insofar as sensitivity (95.40%), specificity (78.69%), positive predictive value (48.54%), negative predictive value (98.78%) and accuracy (81.60%) are concerned. With respect to the categorical variables (BI-RADS categories 3, 4 and 5), the area under the receiver operating characteristic (ROC) curve was 94.41 for SONOBREAST (range 92.20–96.62) and 89.99 for BI-RADS (range 86.60–93.37). Conclusions: The accuracy of the SONOBREAST model is identical to that found with BI-RADS when the same parameters are used with respect to the cut-off point at which malignancy is suspected. Regarding the continuous probability of malignancy with BI-RADS categories 3, 4 and 5, SONOBREAST permits a more precise and individualized evaluation.